Tag Archives: First

Loxley House gives patients their first COVID-19 shots

GENERAL practitioners in Bathurst are now able to vaccinate residents against COVID-19. On Monday, Loxley House Family Practice’s Dr Vidya Murugiah administered the facility’s first dose of the Oxford/AstraZeneca vaccine to Stuart Simmons. The 72-year-old said he felt a responsibility to get the vaccine now that it is available and he is eligible. “I think… Read More »

Cancer symptoms: The first warning sign of nasopharyngeal cancer – a painless swelling

In addition, having a job where you’re regularly exposed to hardwood dust is a risk factor. Having a first-degree relative, such as a parent or sibling, who’s had the condition, also increases your risk of the condition. If you’re worried, the first step to take is to speak to your GP – they will be… Read More »

‘Brand doesn’t matter. Get the first vaccine available,’ Dr. Vin Gupta says

Intensive-care unit and lung doctor Dr. Vin Gupta told CNBC’s “The News with Shepard Smith” that patients should stop weighing the pros and cons of which Covid vaccine is better and get the first shot available into their arms as soon as possible, despite a new Israeli study that shows the Pfizer vaccine actually stops… Read More »

Jamie Lynn Spears Speaks for the First Time About Daughter Maddie’s Accident

Four years ago this February, the daughter of Zoey 101 star and country singer Jamie Lynn Spears, Maddie, suffered a devastating accident when the ATV Maddie was driving flipped into a pond, trapping then eight-year-old under the water. Jamie Lynn and her husband Jamie Watson immediately dived into the water, but were unable to pull… Read More »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »